SGS France, expert in the inspection, analysis, certification and control of industrial products, has confirmed the closing of the acquisition announced last October of IDEA Tests, a company specialised in clinical, microbiological and in-vitro tests for the cosmetics industry.
The IDEA Tests Group, established in 1999 by Benoit Latouche, specialises in the evaluation of efficacy (in vivo and in vitro), tolerance, toxicology, microbiology, as well as regulatory support for the marketing of finished products and cosmetic ingredients. IDEA Tests’ expertise complements SGS France’s “Cosmetics & Hygiene” offer. IDEA Tests has three sites in France (Martillac, Talence, Plouzané) and one in Europe (Bucharest), and employs 80 people.
“France is the world’s leading cosmetics exporter, ahead of Germany and the United States. SGS is the world leader in testing, inspection and certification. This targeted acquisition, which enriches our offer dedicated to the quality and performance of cosmetic products, was one of our major axes for the satisfaction of our French and European customers, whether they are raw material manufacturers, industrialists or distributors. IDEA Tests is still one of the largest independent players capable of handling all aspects of testing (in vitro, microbiology and clinical trials). The synergies with our group are innumerable, in terms of complementary service offers or presence with our customers,” said Alain Guy, Chairman of SGS Group France.
“We share with SGS common values of customer satisfaction and innovation. Joining a group like SGS marks a …
